Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

531
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
531
Cancer Survival Analysis01:21

Cancer Survival Analysis

472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Cancer02:18

Cancer

50.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
50.0K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

481
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
481
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake.

Cancer·2026
Same author

Differences in Lung Cancer Survival by Demographic Characteristics and Social Determinants of Health, United States, 2010-2020.

Public health reports (Washington, D.C. : 1974)·2026
Same author

Use of Cancer Screening Tests, United States, 2023.

Preventing chronic disease·2025
Same author

Baseline Estimates of Colorectal Cancer Screening Among Adults Aged 45 to 75 Years, Behavioral Risk Factor Surveillance System, 2022.

Preventing chronic disease·2025
Same author

Estimating the long-term health impact and program cost-effectiveness of providing direct screening services to low-income, medically underserved patients through the Colorectal Cancer Control Program (CRCCP).

Cancer causes & control : CCC·2025
Same author

Building healthcare-community partnerships: process evaluation of a coalition approach to addressing cancer survivors' health-related social needs.

BMC health services research·2025

Related Experiment Video

Updated: Sep 25, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

6.6K

Cancer Screening Test Use-U.S., 2019.

Susan A Sabatino1, Trevor D Thompson1, Mary C White1

  • 1Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

American Journal of Preventive Medicine
|April 26, 2022
PubMed
Summary
This summary is machine-generated.

Cancer screening rates for breast, cervical, and colorectal cancers remain below national targets. Disparities in screening use exist among various sociodemographic and healthcare access groups.

More Related Videos

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.3K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Related Experiment Videos

Last Updated: Sep 25, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

6.6K
Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.3K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Area of Science:

  • Public Health
  • Preventive Medicine
  • Cancer Epidemiology

Background:

  • The U.S. Preventive Services Task Force recommends regular cancer screenings.
  • Screening utilization rates have not met national Healthy People 2020 targets.
  • Early detection through screening significantly reduces cancer mortality.

Purpose of the Study:

  • To assess the proportion of eligible adults up-to-date with breast, cervical, and colorectal cancer screenings.
  • To compare current screening rates against Healthy People 2020 objectives.
  • To identify disparities in cancer screening uptake.

Main Methods:

  • Utilized data from the 2019 National Health Interview Survey.
  • Analyzed screening completion for breast (women 50-74), cervical (women 21-65), and colorectal (adults 50-75) cancers.
  • Examined screening rates across sociodemographic and healthcare access factors.

Main Results:

  • Breast cancer screening: 76.2%, Cervical cancer screening: 76.4%, Colorectal cancer screening: 68.3%.
  • Some subgroups met breast and colorectal screening targets, but cervical screening fell short for all.
  • Lower education, income, rural residence, lack of insurance, and Medicaid coverage were linked to lower screening use.

Conclusions:

  • National targets for breast, cervical, and colorectal cancer screening were not met in 2019.
  • Monitoring screening trends is crucial for intervention development.
  • Addressing disparities is essential for improving cancer screening equity.